Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-29 4 S $0.14 $700 D/D (5,000) 15,801,269 0 %
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-29 4 S $0.00 $0 I/I (0) 15,801,269 0 %
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-30 4 S $0.00 $0 I/I (0) 15,795,769 0 %
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-30 4 S $0.13 $715 D/D (5,500) 15,795,769 0 %
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-16 4 S $6.52 $3,539,235 D/D (511,676) 1,897,666 0 -
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-16 4 S $0.00 $0 I/I (0) 1,897,666 0 -
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-17 4 S $6.20 $6,934,172 D/D (1,106,210) 791,456 0 %
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-17 4 S $0.00 $0 I/I (0) 791,456 0 %
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-18 4 S $5.48 $3,756,995 D/D (685,583) 105,873 0 %
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-18 4 S $0.00 $0 I/I (0) 105,873 0 %
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-28 4 OE $0.00 $0 D/D 7,130,806 7,223,346 0 -
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-28 4 OE $0.00 $0 I/I 0 7,223,346 0 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-07-30 4 S $2.69 $183,562 I/I (68,188) 977,775 0 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-08-02 4 S $2.40 $463,046 I/I (192,775) 785,000 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-04 4 B $2.69 $268,590 I/I 100,000 39,200,000 1.5 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-05 4 B $2.77 $69,295 I/I 25,000 39,225,000 1.5 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-06 4 B $2.83 $70,630 I/I 25,000 39,250,000 1.5 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-02-03 4 A $3.95 $1,319 I/I 334 3,965,000 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-02-07 4 B $0.00 $0 I/I 450,000 4,415,000 1.42 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-06-26 4 S $0.61 $1,682,010 I/I (2,746,138) 1,668,862 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-06-27 4 S $0.52 $486,888 I/I (937,404) 731,458 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-05-19 4 B $0.63 $15,261 D/D 24,224 3,384,224 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-05-19 4 B $0.63 $30,522 I/I 48,448 3,384,224 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-07-06 4 OE $0.35 $4,179,000 D/D 11,940,000 15,324,224 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-07-06 4 OE $0.35 $8,358,000 I/I 23,880,000 15,324,224 0 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 15 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us